This study was undertaken to determine molecular types and genetic similarity among V. vulnificus isolates by RAPD analysis.
INTRODUCTION
DNA-based methods have recently been used for epidemiologic investigations of the bacterial strains. Among these molecular methods, restriction fragment length polymorphism (RFLP) has the advantage of being easy and rapid to perform, but it holds such disadvantages that the number of possible types is limited, with certain patterns appearing very commonly, so sometimes geographically distinct strains appear identical (1) . Greater resolving power can be achieved by using a moderately repeated DNA sequence as a probe or by electrophoretic karyotyping by pulse-field gel electrophoresis (PFGE). But, the disadvantages of both of these procedures are the greater cost and time required (1) . The random amplified polymorphic DNA (RAPD) assay that is based on the polymerase chain reaction (PCR) was introduced to overcome the above drawbacks of molecular methods for genetic studies (2) . This method uses arbitrarily chosen 10-mer primers in conjunction with PCR, providing a variation of genomic DNA. Information is not required about flanking sequences of regions to be amplified in RAPD. Since each 10-mer primer screens 20 nucleotides for each amplified product, the polymorphisms are efficiently recognized (2) .
Vibrio vulnificus infection is one of the most fatal diseases in Korea. This infection breaks out mainly in the southwestern coastal areas of Korea (3). There have been a lot of reports about the clinical manifestations and biologic characteristics of this infection, but molecular typing of V. vulnificus for epidemiological and genetic study hasn't been reported. Serotyping has been frequently used to differentiate V. vulnificus strains in Korea: most of V. vulnificus isolates have 04 serotype (4) . But these V. vulnificus isolates disclosed various degrees of biochemical reaction profiles by the ATB 32GN system (API systems, La Balme-Les Grottes, France). These findings suggest that diverse biotypes exist in the same serotype (5) .
For the epidemiological study of V. vulnificus infection in Korea, this study was based on 13 V. vulnificus strains from Japanese National Institute of Health and O11 represented only one strain each, and these strains came from JNIH (Table II).
Molecular Typing by RAPD Patterns Each of 97 V. vulnificus strains was analyzed with nine individual primers by the RAPD method. Nine primers used in this study were OPA-1 , OPA-2, OPA-4, OPA-5, OPA-7, OPA-9, OPA-12, OPA-17 and OPA-20 . These were selected from 20 primers tested for their capacities to discriminate variability and their reproducibilities. All amplification was repeated at least twice . In each case, the most intense bands in the patterns were reproducible . Each primer generated between one and five major bands for individual strains. Examples of the patterns obtained with OPA-4 primer are presented in Fig. 1 . The RAPD patterns by OPA-4 primer, having three to five bands between 300 bp and 1 ,300 bp, represent the genetic diversity among the isolates (Fig. 1) . (one strain), 1991 (three strains), 1994 (three strains) and 1995 (two strains).
Four WUH and two JNIH strains composed of type III. The six strains of type IV were from JNIH ( Fig. 2) .
Genetic Similarity
The distribution of genetic similarity values was 0.24 to 1.00 in all isolates, thus the isolates had a wide range of similarity values. The mean similarity values of all isolates, types I, II, III and IV, were 0.76, 0.84, 0.66, 0.55 and 0.48, respectively (Table III) .
Relation between Serotypes and RAPD Types
The most common O4 serotype strains were distributed into RAPD type I (58 strains), II (17 strains), III (three strains) and IV (two strains). The strains having O14 serotype were divided into type III (two strains) and II (one strain).
Serotype O13 strains belonged to types I and II; R serotype to type II and III.
Type IV included O3, O7, O8 and O9 serotype strains. The relationship between serotype and RAPD type was represented in Table II . 
